Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Earnings Analysis

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) has no confirmed upcoming earnings date. Last quarter (2026-03-26) it missed with EPS -0.66 USD vs 0.05 USD est (-1420%). It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E -29.41.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does LMRI next report earnings?

No confirmed upcoming earnings date is currently scheduled for LMRI. This page updates as the calendar is published.

LMRI earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-26-0.66 USD0.05 USD-1420%Miss
2025-12-03-0.03397 USDn/an/an/a

Beat rate: 0/1 (0%) over reported quarters with consensus data.

LMRI valuation and analyst view

Trailing P/E-29.41
Trailing EPS-0.28102 USD
Price / book1.70
Dividend yield0.00%
Market cap1.03B
Analyst consensusStrong Buy (2 buy / 0 hold / 0 sell)
Avg price target9 USD

Related research pages

Frequently asked questions

When is Lumexa Imaging Holdings, Inc. Common Stock (LMRI)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for LMRI. This page updates as the calendar is published.

Did LMRI beat earnings last quarter?

In its 2026-03-26 report, LMRI posted EPS of -0.66 USD versus a 0.05 USD estimate — a miss of 1420%.

What is LMRI's earnings track record?

Over the last 1 reported quarters with consensus data, LMRI beat estimates 0 times (0%).

What is LMRI's current P/E ratio and EPS?

LMRI trades at a trailing P/E of -29.41 on trailing EPS of -0.28101783152063653 USD.

What do analysts rate LMRI?

Analyst consensus is "Strong Buy" across 2 ratings (1 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 9 USD.